Rodney R. Sweetland, III leads CAMRIS at the intersection of science, public policy, and national service.

As President, he directs a research and program management organization that supports some of the United States government’s most important missions in military health, biomedical research, and international development. CAMRIS teams work alongside scientists, physicians, and policymakers to accelerate research, strengthen global health systems, and protect the health and readiness of U.S. service members and populations worldwide. 

Mr. Sweetland’s leadership philosophy is rooted in the idea that government contracting represents one of the most powerful forms of public-private partnership. When properly structured and responsibly administered, these collaborations enable private-sector innovation and management discipline to amplify public resources and achieve outcomes that neither sector could accomplish alone.

His own career reflects that philosophy. Over more than thirty years, he has built a reputation for navigating the complex intersection of law, science, and government operations. His journey at CAMRIS began as outside counsel and evolved through successive leadership roles (including General Counsel and Chief Operating Officer) before he was appointed President in 2021. That progression gives him a uniquely comprehensive understanding of both the legal frameworks and operational realities that shape federal research and development programs.

Under his leadership, CAMRIS continues to expand its work supporting agencies such as the Department of Defense and the National Institutes of Health, advancing programs ranging from infectious disease research to vaccine development and global health initiatives.

Earlier in his career, Mr. Sweetland served as an officer in the United States Army Reserve. The experience reinforced a lifelong commitment to public service and to supporting the institutions that safeguard national security and public health.

A frequent commentator on issues related to government contracting and intellectual property, Mr. Sweetland has published in these fields and is widely respected for his expertise in the governance and administration of complex federal programs.

He holds a Juris Doctor from the George Washington University Law School and a Bachelor of Science from Western Michigan University.

Mr. Sepp is an enterprise architect of biomanufacturing with more than 25 years of experience designing, building, and scaling complex biologics manufacturing processes and organizations from the ground up. A rare combination of deep process engineering expertise and executive governance acumen, Mr. Sepp holds a Project Management Professional (PMP) certification that serves as the governance framework bridging his technical foundation in biochemical and microbial engineering with strategic organizational leadership—enabling him to translate platform-level science into sustainable, compliant, and high-performing manufacturing enterprises.

Mr. Sepp's career spans the full arc of biomanufacturing infrastructure development, from early R&D automation and facility design to multi-hundred-million-dollar CDMO program management. At Lonza Biologics, he spearheaded the implementation of GMP automation platforms (DeltaV, Rockwell), led a complex brownfield facility relocation coordinating across electrical, instrumentation, and controls engineering teams, and managed cross-functional R&D programs supporting clinical and commercial biologics for global pharmaceutical clients. At Emergent BioSolutions, he directed the Manufacturing Science and Technology function supporting more than $100M in annual biologics operations, architected a multi-platform (viral, mammalian, and microbial) single-use technology transfer framework, and led a $14M capital investment in GMP single-use manufacturing technology that modernized capabilities and reduced production cycle times. He served as the primary technical interface to the FDA, BARDA, and global pharmaceutical partners throughout technology transfer, validation, and regulatory approval, while also contributing M&A product due diligence expertise on transactions exceeding $100M in enterprise value.

In 2020, Mr. Sepp joined CAMRIS International to lead his most consequential organizational build and leadership role to-date. As Vice President of Programs at CAMRIS and Program Manager of the Pilot Bioproduction Facility (PBF) at the Walter Reed Army Institute of Research (WRAIR), Mr. Sepp directs a $90M, 10-year government CDMO enterprise—standing up the organization's Quality Assurance, QC, Manufacturing Science and Technology, PMO, and Lean operational excellence functions from the ground up, scaling the workforce from 33 to more than 60 staff, and generating more than $20M in incremental contract revenue through interagency and private sector partnerships. Under his CAMRIS staff and business strategy leadership, the PBF has expanded its capabilities across mRNA vaccines, monoclonal antibodies, viral vectors, and microbial biologics platforms, positioning WRAIR as a strategic national asset for pandemic preparedness and defense biomedical manufacturing.

Mr. Sepp earned his M.S. in Microbial Engineering from the University of Minnesota, where his thesis research focused on novel chromatography resin development for biologics production, and his B.S. in Bioengineering from the University of Illinois. He is also an active member of the International Society for Pharmaceutical Engineering (ISPE) local chapter.

Matthew Bunai is an innovative and established professional with over 15 years of business management experience. He has a strong background in international and domestic project and program implementation and logistics management, corporate operations, workflow and process optimization, information and data security, customer relations, and vendor and personnel management. Mr. Bunai has effectively conceptualized, developed, and implemented successful business models that have resulted in turning underperforming business units into high-functioning and profitable ventures. He specializes in auditing and designing key functional processes to automate and streamline activity, resulting in high-quality, scalable operations while decreasing indirect costs and improving profitability. He has developed and executed successful project plans and process designs for the Department of Defense, the National Institutes of Health, and the Department of Veteran Affairs in both domestic and international environments. This includes implementing projects in diverse and, at times, austere environments on five continents, including overseeing the establishment of project operations in Cairo, Egypt, and Kathmandu, Nepal. Mr. Bunai navigates programs and departments with a combination of common sense and critical thinking, as well as a commitment to quality. He holds true to superlative customer service standards, the successes of which are evidenced by the cultivation, loyalty, and growth of existing client contracts under his management. He has extensive management experience in bilingual and multicultural environments and brings a dedication to efficiency that has resulted in success in all projects he has undertaken.

Prior to his current role, Mr. Bunai served as Director of Finance and Operations, Director of Operations and Business Infrastructure, and Teleradiology Program Director. He attended the University of Maryland, College Park, where he earned Bachelor of Arts degrees in both Economics and Government and Politics and is a certified Project Management Professional (PMP).